Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
2.
Eur J Gynaecol Oncol ; 36(3): 348-50, 2015.
Article in English | MEDLINE | ID: mdl-26189269

ABSTRACT

Endometrial carcinoma is the most common invasive neoplasm of the female genital tract and is associated to the elevated levels of unopposed estrogen, especially in postmenopause. Ovarian Steroid cell tumors are rare tumors and they are named according to the origin of cell. The most common cancer of the female genital tract is the endometrial adenocarcinoma and it accounts for 7% of all invasive cancers in women. In the present case report, the authors present a 59-year-old multiparous woman with a postmenopausal bleeding complaint and they discuss the case of ovarian steroid cell tumor associated with endometrioid adenocarcinoma of endometrium. Endometrial adenocarcinoma is the most common cancer of female genital tract and its contemporarity with an ovarian steroid cell tumor is extremely rare.


Subject(s)
Carcinoma, Endometrioid/pathology , Endometrial Neoplasms/pathology , Neoplasms, Multiple Primary/pathology , Ovarian Neoplasms/pathology , Sex Cord-Gonadal Stromal Tumors/pathology , Female , Humans , Middle Aged
3.
Hum Exp Toxicol ; 33(12): 1297-301, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24505054

ABSTRACT

Drug-related skin disorders may occur in many different ways. Despite pigmentary changes being less important for morbidity, these changes precipitate depressed mood and reduce self-confidence. Testosterone is a steroid hormone from the androgen group and primarily used for the treatment of hypogonadism in males. Testosterone replacement can cause skin problems like acne, hair loss, redness, pain, or infection at the injection site. The study was conducted on a 49-year-old man with adult onset idiopathic hypogonadotropic hypogonadism, which is an acquired form of isolated gonadotropin-releasing hormone deficiency. He was presented with lack of energy and decreased sexual function 10 years ago and was given an oil-based injectable blend of four esterized testosterone compounds as hormone replacement treatment in a urology polyclinic. He was referred to our polyclinic by endocrinologist because of progressive hyperpigmentation marked on his face and oral mucosa. In the present study, we report the first testosterone therapy-related facial and oral mucosal hyperpigmentation and acanthosis nigricans in the same patient.


Subject(s)
Acanthosis Nigricans/chemically induced , Hormone Replacement Therapy/adverse effects , Hyperpigmentation/chemically induced , Testosterone/adverse effects , Acanthosis Nigricans/pathology , Face , Humans , Hyperpigmentation/pathology , Hypogonadism/drug therapy , Injections , Male , Middle Aged , Mouth Mucosa/pathology , Skin/pathology , Testosterone/therapeutic use
5.
Clin Neuropathol ; 28(6): 440-4, 2009.
Article in English | MEDLINE | ID: mdl-19919818

ABSTRACT

OBJECTIVE: Chronic otitis media is a potentially serious disease because of its complications, most of which are common in conjunction with cholesteatomas. There is variance in the terminology used by neurosurgeons, otorhinolaryngologists and neuropathologists. Synonyms for cholesteatoma found in the literature include epidermoid tumor, epidermoid cysts and epithelial inclusion cyst. Intracranial extension of an acquired cholesteatoma is a rarely documented occurrence. PATIENTS/MATERIAL AND METHODS: A 47-year-old woman who had undergone a right tympanomastoidectomy 20 years previously, presented with a long history of mild headaches that had become progressively more severe over the last 3 years. Clinical and radiological evaluation of the patient raised the suspicion of an intracranial cholesteatoma. RESULTS: A right temporal craniotomy was performed. The mass was completely excised and histopathological study revealed the tumor to be a cholesteatoma. The patient's post-operative recovery was uneventful. CONCLUSIONS: Cholesteatomas possess the capacity for eroding bone and can have an insidious onset, but once established, grows relentlessly and destroys neighboring structures. Since a gradual intracranial involvement does not usually cause acute symptoms of increased intracranial pressure, the correct diagnosis may be difficult. Detailed clinical and radiographic studies in particular are diagnostically helpful. Because of the high incidence of delayed recurrence, life-long follow-up is required. The inconsistency in the histopathological classification of intracranial cholesteatomas should be clarified.


Subject(s)
Brain Diseases/diagnosis , Cholesteatoma/diagnosis , Brain Diseases/complications , Brain Diseases/surgery , Cholesteatoma/complications , Cholesteatoma/surgery , Chronic Disease , Craniotomy , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Otitis Media/etiology , Treatment Outcome , Vertigo/etiology
6.
Eur J Gynaecol Oncol ; 27(4): 425-8, 2006.
Article in English | MEDLINE | ID: mdl-17009644

ABSTRACT

Synchronous primary cancers of the endometrium and ovary are found in 5% of women with endometrial cancer and 10% of women with ovarian cancer. In the present case, a multigravid 46-year-old woman complained of lower abdominal pain and abdominal distension. She did not define abnormal uterine bleeding. Screening ultrasound revealed a papillary containing structure, irregular, cystic 16 x 15 x 10 cm right ovarian mass. Preoperative endometrial biopsy revealed endometrioid adenocarcinoma. Ascites sampling, radical hysterectomy, bilateral salpingo-oophorectomy, pelvic and paraaortic lymphadenectomy, omentectomy, appendectomy and cytologic sampling of the undersurface of the diaphragm were carried out. Intraoperative and histological examinations showed Stage IIIC papillary serous carcinoma and stage IC endometrioid adenocarcinoma. Synchronous genital tract neoplasms constitute a more common clinical problem than would generally be expected.


Subject(s)
Carcinoma, Endometrioid/diagnosis , Endometrial Neoplasms/diagnosis , Neoplasms, Multiple Primary/etiology , Ovarian Neoplasms/diagnosis , Carcinoma, Endometrioid/surgery , Endometrial Neoplasms/surgery , Female , Humans , Middle Aged , Neoplasms, Multiple Primary/pathology , Ovarian Neoplasms/surgery
7.
Arch Gynecol Obstet ; 272(2): 173-5, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15605271

ABSTRACT

INTRODUCTION: Short rib-polydactyly syndrome (SRPD) is an autosomal recessive, lethal skeletal dysplasia. It is characterized by short limb dwarfism, short ribs with thoracic hypoplasia, polydactyly, and multiple anomalies of major organs. CASE REPORT: We report a case of SRPD subtype II (Majewski) that was detected in the 36th week of gestation, showing hydropic change, narrow thorax, shortened limbs, protuberant abdomen, micromelia, polydactyly and extremely low set ears, depressed nasal bridge, and cleft palate. The family was informed of the fatal outcome of the condition. Delivery was induced, and the baby died just after the birth. DISCUSSION: Prenatal diagnosis is established with postmortem radiographic and pathologic examinations.


Subject(s)
Short Rib-Polydactyly Syndrome/diagnosis , Ultrasonography, Prenatal , Adult , Diagnosis, Differential , Fatal Outcome , Female , Humans , Infant, Newborn , Male , Pregnancy , Short Rib-Polydactyly Syndrome/diagnostic imaging , Short Rib-Polydactyly Syndrome/pathology
SELECTION OF CITATIONS
SEARCH DETAIL